版本:
中国

BRIEF-Genmab Q1 net sales of Darzalex at $255 million

April 18 GENMAB A/S

* GENMAB ANNOUNCES NET SALES OF DARZALEX®(DARATUMUMAB) FOR FIRST QUARTER OF 2017

* NET SALES OF DARZALEX IN Q1 OF 2017 TOTALED $255 MILLION

* SAYS WILL RECEIVE ROYALTIES ON WORLDWIDE NET SALES FROM JANSSEN BIOTECH, INC Source text for Eikon: Further company coverage: (Gdynia Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐